𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The safety of breast-conserving therapy in patients with breast cancer aged ≤40 years

✍ Scribed by Marloes van der Leest; Lisette Evers; Maurice J. C. van der Sangen; Philip M. Poortmans; Lonneke V. van de Poll-Franse; Ans J. Vulto; Grard A. P. Nieuwenhuijzen; Stefan J. Brenninkmeijer; Geert-Jan Creemers; Adri C. Voogd

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
137 KB
Volume
109
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND.

The objectives of this study were to study the probability of local control after breast‐conserving therapy (BCT) in a large population of patients with early‐stage breast cancer aged ≤40 years and to determine which factors had prognostic value.

METHODS.

All patients (n = 758) aged ≤40 years with clinical stage I or II breast cancer who underwent BCT in general hospitals in the southern part of the Netherlands between 1988 and 2002 were selected for the current analysis. BCT included local excision of the tumor followed by irradiation of the breast. Of 758 patients, 329 patients (43%) received adjuvant systemic treatment, and 36 patients (5%) underwent a microscopically incomplete excision. The median follow‐up was 8.5 years.

RESULTS.

During follow‐up, 95 patients developed a local recurrence without evidence of distant disease at the time the recurrence was diagnosed. Contralateral breast cancer was diagnosed in 59 patients. The 5‐ and 10‐year actuarial local recurrence rates were 9.0% (95% confidence interval [95% CI], 6.6–11.4%) and 17.9% (95% CI, 14.1–21.7%), respectively. In a multivariate analysis, adjuvant systemic treatment reduced the risk of local recurrence (hazards ratio [HR], 0.47; 95% CI, 0.28–0.78) and contralateral breast cancer (HR, 0.46; 95% CI, 0.24–0.87) by >50%.

CONCLUSIONS.

The risk of local recurrence in young patients who underwent BCT was reduced strongly by using adjuvant systemic treatment. This finding may provide an argument if favor of advising the use of systemic treatment for all patients aged ≤40 years who undergo BCT. Cancer 2007. © 2007 American Cancer Society.

📜 SIMILAR VOLUMES

Eighteen-year results in the treatment o
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy
✍ Brian K. P. Goh; Wei-Sean Yong 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

## Eighteen-Year Results in the Treatment of Early Breast Carcinoma with Mastectomy Versus Breast Conservation Therapy W e applaud the recent report by Poggi et al. 1 regarding the 18-year follow-up data of the National Cancer Institute randomized trial on breast conservation therapy (BCT) versus

Irradiation of the tumor bed alone after
Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy
✍ Vicini, Frank; Kini, Vijay R.; Chen, Peter; Horwitz, Eric; Gustafson, Gary; Beni 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Backgrounds and Objectives: We present the interim findings of our in-house protocol treating the tumor bed alone after lumpectomy with low-dose-rate (LDR) interstitial brachytherapy in selected patients with early-stage breast cancer treated with breast conserving therapy (BCT). Methods: From

Routine mammography is associated with e
Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older
✍ Gary M. Freedman; Penny R. Anderson; Lori J. Goldstein; Alexandra L. Hanlon; Mar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract ## BACKGROUND Reduction in breast carcinoma mortality is a major benefit of screening mammography and has been demonstrated in multiple randomized clinical trials and service screening programs. Another benefit from screening is that it allows the patient a wider choice of treatment op

Eighteen-year results in the treatment o
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy : The National Cancer Institute randomized trial
✍ Matthew M. Poggi; David N. Danforth; Linda C. Sciuto; Sharon L. Smith; Seth M. S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## BACKGROUND Between 1979–1987, the National Cancer Institute conducted a randomized, prospective study of mastectomy (MT) versus breast conservation therapy (BCT) in the treatment of patients with early‐stage breast carcinoma. After a median potential follow‐up of 18.4 years, the aut